Site-specific cancer deaths in cancer of unknown primary diagnosed with lymph node metastasis may reveal hidden primaries

International Journal of Cancer

Volumn 132, Issue 4, 2012, Pages 944-950

  Hemminki, K ^a,b   Bevier, M ^a   Sundquist, J ^b,c   Hemminki, A ^d  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b LUND UNIVERSITY   (Sweden)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

cancer death; hidden primary cancer; lymph nodes; metastases; survival

Indexed keywords

ARTICLE; BREAST TUMOR; CANCER MORTALITY; CANCER OF UNKNOWN PRIMARY SITE; CANCER REGISTRY; CANCER SURVIVAL; CAUSE OF DEATH; CAUSE SPECIFIC SURVIVAL; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; LUNG TUMOR; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIMARY TUMOR; PRIORITY JOURNAL; SURVIVAL RATE; TUMOR LOCALIZATION;

BREAST NEOPLASMS; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; NEOPLASMS, UNKNOWN PRIMARY;

EID: 84871399411     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27678     Document Type: Article

References (32)

1. van de Wouw AJ, Janssen-Heijnen ML, Coebergh JW, et al. Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984-1992. Eur J Cancer 2002; 38: 409-13. (Pubitemid 34121969)
2. Pavlidis N, Fizazi K,. Carcinoma of unknown primary (CUP). Crit Rev Oncol Hematol 2009; 69: 271-8.
3. Greco FA, Oien K, Erlander M, et al. Cancer of unknown primary: progress in the search for improved and rapid diagnosis leading toward superior patient outcomes. Ann Oncol 2012; 23: 298-304.
4. Shu X, Sundquist K, Sundquist J, et al. Time trends in incidence, causes of death, and survival of cancer of unknown primary in Sweden. Eur J Cancer Prev 2012; 21: 281-8.
5. Daugaard G,. Unknown primary tumors. Cancer Treat Rev 1994; 20: 119-47.
6. Kramer A, Hubner G, Schneeweiss A, et al. Carcinoma of unknown primary-an orphan disease? Breast Care (Basel) 2008; 3: 164-70. (Pubitemid 351958138)
7. Disibio G, French SW,. Metastatic patterns of cancers: results from a large autopsy study. Arch Pathol Lab Med 2008; 132: 931-9. (Pubitemid 351918698)
8. Hess KR, Varadhachary GR, Taylor SH, et al. Metastatic patterns in adenocarcinoma. Cancer 2006; 106: 1624-33.
9. Fizazi K, Greco FA, Pavlidis N, et al. Cancer of unknown primary site: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2011; 22: vi64-vi68.
10. Scott CL, Kudaba I, Stewart JM, et al. The utility of 2-deoxy-2-[F-18]fluoro- D -glucose positron emission tomography in the investigation of patients with disseminated carcinoma of unknown primary origin. Mol Imaging Biol 2005; 7: 236-43. (Pubitemid 41348866)
11. Freudenberg LS, Rosenbaum-Krumme SJ, Bockisch A, et al. Cancer of unknown primary. Recent Results Cancer Res 2008; 170: 193-202.
12. Frangioni J,. New technologies for human cancer imaging. J Clin Oncol 2008; 26: 4012-21.
13. Kwee TC, Basu S, Alavi A,. PET and PET/CT for unknown primary tumors. Methods Mol Biol 2011; 727: 317-33.
14. Hemminki K, Liu H, Hemminki A, et al. Power and limits of modern cancer diagnostics: cancer of unknown primary. Ann Oncol 2012; 23: 760-4.
15. Hemminki K, Ji J, Sundquist J, et al. Familial risks in cancer of unknown primary: tracking the primary sites. J Clin Oncol 2011; 29: 435-40.
16. Shu X, Liu H, Ji J, et al. Subsequent cancers in patients diagnosed with cancer of unknown primary (CUP): etiological insights? Ann Oncol 2012; 23: 269-75.
17. Chen LL, Blumm N, Christakis NA, et al. Cancer metastasis networks and the prediction of progression patterns. Br J Cancer 2009; 101: 749-58.
18. Hemminki K, Bevier M, Hemminki A, et al. Survival in cancer of unknown primary site: population-based analysis by site and histology. Ann Oncol 2011; Epub ahead of print.
19. Bevier M, Sundquist J, Hemminki K,. Incidence of cancer of unknown primary in Sweden: analysis by location of metastasis. Eur J Cancer Prev 2012; Epub ahead of print.
20. Chambers AF, Groom AC, MacDonald IC,. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002; 2: 563-72. (Pubitemid 37328923)
21. Kawada K, Taketo MM,. Significance and mechanism of lymph node metastasis in cancer progression. Cancer Res 2011; 71: 1214-18.
22. Langley RR, Fidler IJ,. The seed and soil hypothesis revisited-the role of tumor-stroma interactions in metastasis to different organs. Int J Cancer 2011; 128: 2527-35.
23. Sleeman JP, Nazarenko I, Thiele W,. Do all roads lead to Rome? Routes to metastasis development. Int J Cancer 2011; 128: 2511-26.
24. Schreiber RD, Old LJ, Smyth MJ,. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 2011; 331: 1565-70.
25. Hemminki K, Bevier M, Sundquist J, et al. Cancer of unknown primary (CUP): does cause of death and family history implicate hidden phenotypically changed primaries? Ann Oncol 2012; Epub ahead of print.
26. Hess KR, Abbruzzese MC, Lenzi R, et al. Classification and regression tree analysis of 1000 consecutive patients with unknown primary carcinoma. Clin Cancer Res 1999; 5: 3403-10.
27. Sleeman J, Schmid A, Thiele W,. Tumor lymphatics. Semin Cancer Biol 2009; 19: 285-97.
28. Cochran AJ, Huang RR, Lee J, et al. Tumour-induced immune modulation of sentinel lymph nodes. Nat Rev Immunol 2006; 6: 659-70. (Pubitemid 44298215)
29. Sleeman JP, Thiele W,. Tumor metastasis and the lymphatic vasculature. Int J Cancer 2009; 125: 2747-56.
30. Klein C,. Parallel progression of primary tumours and metastatsis. Nature Rev Cancer 2009; 9: 302-12.
31. Gazdar A,. Personalized medicine and inhibition of EGFR signaling in lung cancer. New Engl J Med 2009; 361: 1018-20.
32. Kwak EL, Bang YJ, Camidge DR, et al. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med 2010; 363: 1693-703.